Brief: Ambu Gets FDA Clearance For Generation Duodenoscopy Solution

Ambu A/S

19/04/2024 08:26

April 19 (Reuters) - Ambu A/S  AMBUb.CO :
    * OBTAINS FDA CLEARANCE FOR NEW  GENERATION DUODENOSCOPY
SOLUTION
    * SOLUTION WILL BE AVAILABLE IN THE MARKET FROM 2024/25, AND
THE
FDA CLEARANCE WILL THEREFORE NOT CHANGE THE FINANCIAL  GUIDANCE
FOR 2023/24

Source text for Eikon:  ID: 
Further company coverage:  AMBUb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))